Here’s what you should know.
1. Several hundreds of people will be able to obtain compensation for the removal of the recalled Rejuvenate and ABGII modular hip implants.
2. The implants recalled in 2012 had a high failure rate associated with metallic corrosion. The related debris was causing tissue and muscle damage requiring complex revision surgeries.
3. The current settlement program is for litigation in New Jersey and Minnesota as well as for individual cases.
More orthopedic/spinal device news:
Providence Medical Technology receives $10.5M new equity financing — 5 points
Stavros Vizirgianakis to lead Misonix as new president, CEO: 5 things to now
NuVasive US Commercial President Matthew Link sells 10.3k shares: 5 key points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
